| Profiles RNS

Profile

MD, Stanford University School of Medicine
DPH/DrPH, Harvard School of Public Health
MPH, Harvard School of Public Health
AB, Harvard College

Websites

	RTI Health Solutions Profile
	LinkedIn

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Hicks B, Kaye JA, Azoulay L, Kristensen KB, Habel LA, Pottegård A. The application of lag times in cancer pharmacoepidemiology: a narrative review. Ann Epidemiol. 2023 Aug; 84:25-32. PMID: 37169040

Bhandari NR, Hess LM, Parikh RC, Sireci AN, Krein PM, Kaye JA. Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the USA. Per Med. 2023 Mar; 20(2):131-142. PMID: 36749615

Johannes CB, Saltus CW, Kaye JA, Calingaert B, Kaplan S, Gordon MF, Andrews EB. The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database. Pharmacoepidemiol Drug Saf. 2022 Jun; 31(6):643-651. PMID: 35224798; PMCID: PMC9321028; DOI: 10.1002/pds.5422;

Parikh R, Hess LM, Esterberg E, Bhandari NR, Kaye JA. Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancer. Thyroid Res. 2022 Feb 12; 15(1):2. PMID: 35151352; PMCID: PMC8840546; DOI: 10.1186/s13044-021-00119-9;

Arana A, Pottegård A, Kuiper JG, Booth H, Reutfors J, Calingaert B, Lund LC, Crellin E, Schmitt-Egenolf M, Kaye JA, Gembert K, Rothman KJ, Kieler H, Dedman D, Houben E, Gutiérrez L, Hallas J, Perez-Gutthann S. Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE). Clin Epidemiol. 2021; 13:1141-1153.View Related Profiles.

Kaye, James
Rothman, Kenneth

PMID: 35002327; PMCID: PMC8721027; DOI: 10.2147/CLEP.S331287;

Fortuny J, Plana E, Kaye JA. Serum lipid trajectories in the years before a lymphoma diagnosis. Leuk Lymphoma. 2022 02; 63(2):291-303. PMID: 34963420

Boeri M, Purdum AG, Sutphin J, Hauber B, Kaye JA. CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma: physician preferences trading off benefits, risks and time to infusion. Future Oncol. 2021 Dec; 17(34):4697-4709. PMID: 34581197

Goyal RK, Jain P, Nagar SP, Le H, Kabadi SM, Davis K, Kaye JA, Du XL, Wang M. Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphoma. Leuk Lymphoma. 2021 06; 62(6):1325-1334. PMID: 33966583

Goyal RK, Nagar SP, Kabadi SM, Le H, Davis KL, Kaye JA. Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real-world evidence from the medicare population. Cancer Med. 2021 04; 10(8):2690-2702. PMID: 33734606; PMCID: PMC8026937; DOI: 10.1002/cam4.3855;

Richardson D, Zhan L, Mahtani R, McRoy L, Mitra D, Reynolds M, Odom D, Hollis K, Kaye JA, Jones C, Hargis J. A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application. Breast Cancer Res Treat. 2021 May; 187(1):113-124. PMID: 33428072; PMCID: PMC8062359; DOI: 10.1007/s10549-020-06082-7;

Showing 10 of 124 results. Show More

Stenehjem DD, Telford C, Unni SK, Bauer H, Sainski A, Deka R, Schauerhamer MB, Ye X, Tak CR, Ma J, Dalvi TB, Gutierrez L, Kaye JA, Tyczynski JE, Brixner DI, Biskupiak JE. BRCA testing and outcomes in women with breast cancer. Breast Cancer Res Treat. 2021 Apr; 186(3):839-850. PMID: 33389410

Goyal RK, Cuyun Carter G, Nagar SP, Nash Smyth E, Price GL, Parikh RC, Huang YJ, Li L, Davis KL, Kaye JA. Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2- metastatic breast cancer in the United States. Expert Rev Pharmacoecon Outcomes Res. 2021 Aug; 21(4):699-710. PMID: 32755262

Bassali J, Gould IG, Kaye JA, Mladsi D, Mehta J. US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma. Clinicoecon Outcomes Res. 2020; 12:317-325. PMID: 32606848; PMCID: PMC7310980; DOI: 10.2147/CEOR.S251070;

Vassilev ZP, Gabarró MS, Kaye JA, Saltus CW, Riedel O, Scholle O, Mehtälä J, Korhonen P, Garbe E, Zong J. Incidence of second primary malignancies in metastatic castration-resistant prostate cancer: results from observational studies in three countries. Future Oncol. 2020 Sep; 16(25):1889-1901. PMID: 32515225

Brown J, Liepa AM, Bapat B, Madhwani S, Lorenzen S, García-Foncillas J, Candrilli SD, Kaye JA. Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom. Eur J Cancer Care (Engl). 2020 Mar; 29(2):e13213. PMID: 31883156

Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP. Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors. J Gastrointest Oncol. 2019 Aug; 10(4):674-687. PMID: 31392048; PMCID: PMC6657323; DOI: 10.21037/jgo.2019.03.11;

Kawai AT, Martinez D, Saltus CW, Vassilev ZP, Soriano-Gabarró M, Kaye JA. Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US. Prostate Cancer. 2019; 2019:5971615. PMID: 31360552; PMCID: PMC6652049; DOI: 10.1155/2019/5971615;

Saltus CW, Vassilev ZP, Zong J, Calingaert B, Andrews EB, Soriano-Gabarró M, Kaye JA. Corrigendum to "Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States". Prostate Cancer. 2019; 2019:3425982. PMID: 31355002; PMCID: PMC6637695; DOI: 10.1155/2019/3425982;

Goyal RK, Carter GC, Nagar SP, Smyth EN, Price GL, Huang YJ, Li L, Davis KL, Kaye JA. Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2- metastatic breast cancer. Curr Med Res Opin. 2019 10; 35(10):1699-1710. PMID: 31060392

Kabadi SM, Goyal RK, Nagar SP, Kaye JA, Davis KL. Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States. Cancer Med. 2019 07; 8(8):3803-3810. PMID: 31144473; PMCID: PMC6639180; DOI: 10.1002/cam4.2268;

Vickers AD, Winfree KB, Cuyun Carter G, Kiiskinen U, Jen MH, Stull D, Kaye JA, Carbone DP. Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis. BMC Cancer. 2019 Apr 15; 19(1):353. PMID: 30987609; PMCID: PMC6466705; DOI: 10.1186/s12885-019-5569-5;

Margulis AV, Fortuny J, Kaye JA, Calingaert B, Reynolds M, Plana E, McQuay LJ, Jan Atsma W, Franks B, de Vogel S, Perez-Gutthann S, Arana A. Proportions of Cancer Cases in Primary Care, Hospital, and Cancer Registry Data Among Patients Treated for Overactive Bladder. Epidemiology. 2019 03; 30(2):e8-e9. PMID: 30489349

Saltus CW, Vassilev ZP, Zong J, Calingaert B, Andrews EB, Soriano-Gabarró M, Kaye JA. Incidence of Second Primary Malignancies in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the United States. Prostate Cancer. 2019; 2019:4387415. PMID: 30886751; PMCID: PMC6388338; DOI: 10.1155/2019/4387415;

Barrows SM, Wright K, Copley-Merriman C, Kaye JA, Chioda M, Wiltshire R, Torgersen KM, Masters ET. Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer. Lung Cancer (Auckl). 2019; 10:11-20. PMID: 30804692; PMCID: PMC6372008; DOI: 10.2147/LCTT.S179349;

Lin HM, Davis KL, Kaye JA, Luptakova K, Nagar SP, Mohty M. Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France. Adv Hematol. 2019; 2019:4625787. PMID: 30838045; PMCID: PMC6374830; DOI: 10.1155/2019/4625787;

Goyal RK, Nagar SP, Kabadi SM, Kaye JA, Seal B, Mato AR. Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United States. Leuk Lymphoma. 2019 04; 60(4):955-963. PMID: 30277099; PMCID: PMC7564890; DOI: 10.1080/10428194.2018.1509320;

Mytelka DS, Nagar SP, D'yachkova Y, La EM, Kaye JA, Candrilli SD, Kasper B, Lopez-Martin JA, Lorenzo M. Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France. Sarcoma. 2018; 2018:2020591. PMID: 30297977; PMCID: PMC6157208; DOI: 10.1155/2018/2020591;

Margulis AV, Fortuny J, Kaye JA, Calingaert B, Reynolds M, Plana E, McQuay LJ, Atsma WJ, Franks B, de Vogel S, Perez-Gutthann S, Arana A. Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom. Epidemiology. 2018 09; 29(5):e41-e42. PMID: 29794511; DOI: 10.1097/EDE.0000000000000856;

Handy CE, Quispe R, Pinto X, Blaha MJ, Blumenthal RS, Michos ED, Lima JAC, Guallar E, Ryu S, Cho J, Kaye JA, Comin-Colet J, Corbella X, Cainzos-Achirica M. Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment. Circulation. 2018 08 14; 138(7):727-734. PMID: 30359131

Chouaid C, Danson S, Andreas S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue MH, Barth J, Hoffmann H, Potter V, Barlesi F, Price M, Chirila C, Hollis K, Sweeney C, Wolowacz S, Kaye JA, Kontoudis I. Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study. Lung Cancer. 2018 10; 124:310-316. PMID: 30119925

La EM, Smyth EN, Talbird SE, Li L, Kaye JA, Lin AB, Bowman L. Treatment patterns and health care resource use in patients receiving multiple lines of therapy for metastatic squamous cell carcinoma of the head and neck in the United Kingdom. Eur J Cancer Care (Engl). 2018 Sep; 27(5):e12862. PMID: 29927010; PMCID: PMC6175088; DOI: 10.1111/ecc.12862;

Andreas S, Chouaid C, Danson S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue MH, Barth J, Hoffmann H, Potter V, Barlesi F, Chirila C, Hollis K, Sweeney C, Price M, Wolowacz S, Kaye JA, Kontoudis I. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS). Lung Cancer. 2018 10; 124:298-309. PMID: 29961557

Kuiper JG, van Herk-Sukel MPP, Castellsague J, Pottegård A, Berglind IA, Dedman D, Gutierrez L, Calingaert B, Hallas J, Sundström A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ, Perez-Gutthann S. Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study. Drugs Real World Outcomes. 2018 Jun; 5(2):109-116.View Related Profiles.

Kaye, James
Rothman, Kenneth

PMID: 29736842; PMCID: PMC5984609; DOI: 10.1007/s40801-018-0133-1;

Nagar SP, Mytelka DS, Candrilli SD, D'yachkova Y, Lorenzo M, Kasper B, Lopez-Martin JA, Kaye JA. Treatment Patterns and Survival among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France. Sarcoma. 2018; 2018:5467057. PMID: 29977133; PMCID: PMC5994280; DOI: 10.1155/2018/5467057;

Parikh RC, Lorenzo M, Hess LM, Candrilli SD, Nicol S, Kaye JA. Treatment patterns and survival among older adults in the United States with advanced soft-tissue sarcomas. Clin Sarcoma Res. 2018; 8:8. PMID: 29744029; PMCID: PMC5932822; DOI: 10.1186/s13569-018-0094-x;

Parikh R, Kurosky SK, Udall M, Chang J, Cappelleri JC, Doherty JP, Kaye JA. Treatment Patterns and Health Outcomes in Platinum-Refractory or Platinum-Resistant Ovarian Cancer: A Retrospective Medical Record Review. Int J Gynecol Cancer. 2018 05; 28(4):738-748. PMID: 29538247; DOI: 10.1097/IGC.0000000000001222;

Saltus CW, Calingaert B, Candrilli S, Lorenzo M, D'yachkova Y, Otto T, Wagner U, Kaye JA. Epidemiology of Adult Soft-Tissue Sarcomas in Germany. Sarcoma. 2018; 2018:5671926. PMID: 29849478; PMCID: PMC5904765; DOI: 10.1155/2018/5671926;

Zuluaga-Sanchez S, Hess LM, Wolowacz SE, D'yachkova Y, Hawe E, Vickers AD, Kaye JA, Bertwistle D. Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States. Sarcoma. 2018; 2018:6703963. PMID: 29785170; PMCID: PMC5892240; DOI: 10.1155/2018/6703963;

Castellsague J, Kuiper JG, Pottegård A, Anveden Berglind I, Dedman D, Gutierrez L, Calingaert B, van Herk-Sukel MP, Hallas J, Sundström A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ, Perez-Gutthann S. A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study). Clin Epidemiol. 2018; 10:299-310.View Related Profiles.

Kaye, James
Rothman, Kenneth

PMID: 29559812; PMCID: PMC5856050; DOI: 10.2147/CLEP.S146442;

Margulis AV, Fortuny J, Kaye JA, Calingaert B, Reynolds M, Plana E, McQuay LJ, Atsma WJ, Franks B, de Vogel S, Perez-Gutthann S, Arana A. Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom. Epidemiology. 2018 03; 29(2):308-313. PMID: 29135571; PMCID: PMC5794229; DOI: 10.1097/EDE.0000000000000786;

Davis KL, Kaye JA, Masters ET, Iyer S. Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib. Curr Oncol. 2018 Feb; 25(1):e40-e49. PMID: 29507494; PMCID: PMC5832290; DOI: 10.3747/co.25.3723;

Hallas J, Margulis AV, Pottegård A, Kristiansen NS, Atsma WJ, Appenteng K, de Vogel S, Kaye JA, Perez-Gutthann S, Arana A. Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study. Basic Clin Pharmacol Toxicol. 2018 Jun; 122(6):612-619. PMID: 29345103; DOI: 10.1111/bcpt.12965;

Grange F, Mohr P, Harries M, Ehness R, Benjamin L, Siakpere O, Barth J, Stapelkamp C, Pfersch S, McLeod LD, Kaye JA, Wolowacz S, Kontoudis I. Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study). Melanoma Res. 2017 12; 27(6):607-618. PMID: 28800027; DOI: 10.1097/CMR.0000000000000372;

Kurosky SK, Mitra D, Zanotti G, Kaye JA. Treatment Patterns and Outcomes of Patients With Metastatic ER+/HER-2- Breast Cancer: A Multicountry Retrospective Medical Record Review. Clin Breast Cancer. 2018 08; 18(4):e529-e538. PMID: 29199086; DOI: 10.1016/j.clbc.2017.10.008;

Goyal RK, Tzivelekis S, Rothman KJ, Candrilli SD, Kaye JA. Time trends in utilization of G-CSF prophylaxis and risk of febrile neutropenia in a Medicare population receiving adjuvant chemotherapy for early-stage breast cancer. Support Care Cancer. 2018 02; 26(2):539-548.View Related Profiles.

Kaye, James
Rothman, Kenneth

PMID: 28921379

Brett Hauber A, Mange B, Price MA, Wolin D, Bensink M, Kaye JA, Chandler D. Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey. Support Care Cancer. 2018 01; 26(1):251-260. PMID: 28785862; DOI: 10.1007/s00520-017-3841-2;

Cronin-Fenton DP, Kjærsgaard A, Nørgaard M, Pedersen IS, Thomassen M, Kaye JA, Gutierrez L, Telford C, Lewis J, Tyczynski JE, Sørensen HT. Clinical outcomes of female breast cancer according to BRCA mutation status. Cancer Epidemiol. 2017 08; 49:128-137.View Related Profiles.

Sorensen, Henrik
Kaye, James

PMID: 28601786

Kaye JA, Margulis AV, Fortuny J, McQuay LJ, Plana E, Bartsch JL, Bui CL, Perez-Gutthann S, Arana A. Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias. Pharmacotherapy. 2017 Jun; 37(6):673-683. PMID: 28370075; PMCID: PMC5518180; DOI: 10.1002/phar.1932;

Odom D, Mladsi D, Purser M, Kaye JA, Palaka E, Charter A, Jensen JA, Sellami D. A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma. J Skin Cancer. 2017; 2017:6121760. PMID: 28607774; PMCID: PMC5457749; DOI: 10.1155/2017/6121760;

Chirila C, Mitra D, Colosia A, Ling C, Odom D, Iyer S, Kaye JA. Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysis. Curr Med Res Opin. 2017 08; 33(8):1457-1466. PMID: 28463012; DOI: 10.1080/03007995.2017.1325730;

Davis KL, Lenz C, Houghton K, Kaye JA. Clinical Outcomes of Crizotinib in Real-World Practice Settings for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017 May 01; 98(1):238-239. PMID: 28587013

Davis KL, Lenz C, Houghton K, Kaye JA. Real-World Clinical Outcomes of Crizotinib Treatment in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases. Int J Radiat Oncol Biol Phys. 2017 May 01; 98(1):239. PMID: 28587016

Harries M, Mohr P, Grange F, Ehness R, Benjamin L, Siakpere O, Barth J, Stapelkamp C, Pfersch S, McLeod L, Wolowacz S, Kaye JA, Kontoudis I. Treatment patterns and outcomes of Stage IIIB/IIIC melanoma in France, Germany and the UK: A retrospective and prospective observational study (MELABIS). Int J Clin Pract. 2017 May; 71(5). PMID: 28508460; PMCID: PMC5697614; DOI: 10.1111/ijcp.12946;

Colosia A, Khan S, Hackshaw MD, Oglesby A, Kaye JA, Skolnik JM. A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma. Sarcoma. 2016; 2016:3597609. PMID: 27516726; PMCID: PMC4969544; DOI: 10.1155/2016/3597609;

Marion S, Tzivelekis S, Darden C, Price MA, Sherif B, Garcia J, Kaye JA, Chandler D. "Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale. Support Care Cancer. 2016 09; 24(9):3889-96. PMID: 27108262; DOI: 10.1007/s00520-016-3193-3;

Davis KL, Côté I, Kaye JA, Mendelson E, Gao H, Perez Ronco J. Real-World Assessment of Clinical Outcomes in Patients with Lower-Risk Myelofibrosis Receiving Treatment with Ruxolitinib. Adv Hematol. 2015; 2015:848473. PMID: 26635878; PMCID: PMC4655278; DOI: 10.1155/2015/848473;

Davis KL, Lin HM, Hui A, Zhang S, Kaye JA. Assessment of Real-World Treatment Patterns and Outcomes In Relapsed or Refractory Multiple Myeloma: Evidence From A Brief Multi-Country Survey of European Physicians. Value Health. 2015 Nov; 18(7):A682. PMID: 26533822; DOI: 10.1016/j.jval.2015.09.2032;

Kurosky S, Mitra D, Zanotti G, Kaye JA. Patient Characteristics And Treatment Patterns In Er+/Her2- Metastatic Breast Cancer In The Uk: Results From A Retrospective Medical Record Review. Value Health. 2015 Nov; 18(7):A492. PMID: 26532761; DOI: 10.1016/j.jval.2015.09.1369;

Goyal RK, Davis KL, Côté I, Mounedji N, Kaye JA. Health Care Resource use and Costs Among Polycythemia Vera Patients in the United States: Results from an Observational Cohort Study. Value Health. 2015 Nov; 18(7):A482-3. PMID: 26532707

Nash Smyth E, La E, Talbird S, Li L, Kaye JA, Lin AB, Bowman L. Treatment Patterns and Health Care Resource use (Hcru) Associated with Repeatedly Treated Metastatic Squamous Cell Carcinoma of the Head and Neck (Scchn) in the United Kingdom (Uk). Value Health. 2015 Nov; 18(7):A450-1. PMID: 26532533; DOI: 10.1016/j.jval.2015.09.1136;

Karve S, Lorenzo M, Liepa AM, Hess LM, Kaye JA, Calingaert B. Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims Database. J Gastric Cancer. 2015 Jun; 15(2):87-104. PMID: 26161282; PMCID: PMC4496446; DOI: 10.5230/jgc.2015.15.2.87;

Smyth EN, Bapat B, Ball DE, André T, Kaye JA. Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study. Clin Ther. 2015 Jun 01; 37(6):1301-16. PMID: 25907619; DOI: 10.1016/j.clinthera.2015.03.016;

Whiteley J, Iyer S, Candrilli SD, Kaye JA. Treatment patterns and prognostic indicators of response to therapy among patients with chronic myeloid leukemia in Australia, Canada, and South Korea. Curr Med Res Opin. 2015 Feb; 31(2):299-314. PMID: 25427232; DOI: 10.1185/03007995.2014.991817;

Davis KL, Goyal RK, Able SL, Brown J, Li L, Kaye JA. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer. Lung Cancer. 2015 Feb; 87(2):176-85. PMID: 25532680; DOI: 10.1016/j.lungcan.2014.11.002;

Kontoudis I, Harries M, Mohr P, Grange F, Ehness R, Benjamin L, Siakpere O, Barth J, Stapelkamp C, Pfersch S, McLeod L, Kaye JA, Wolowacz S. Economic Burden of Melanoma in Three European Countries: A Retrospective Observational Study. Value Health. 2014 Nov; 17(7):A626. PMID: 27202211; DOI: 10.1016/j.jval.2014.08.2227;

Cuyún Carter G, Barrett AM, Kaye JA, Liepa AM, Winfree KB, John WJ. A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer. Cancer Manag Res. 2014; 6:437-49. PMID: 25364274; PMCID: PMC4211870; DOI: 10.2147/CMAR.S63603;

Police RL, Trask PC, Wang J, Olivares R, Khan S, Abbe A, Colosia A, Njue A, Sherrill B, Ruiz-Soto R, Kaye JA, Hamadani M. Randomized controlled trials in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis. Clin Lymphoma Myeloma Leuk. 2015 Apr; 15(4):199-207. PMID: 25445467; DOI: 10.1016/j.clml.2014.09.008;

Njue A, Colosia A, Trask PC, Olivares R, Khan S, Abbe A, Police R, Wang J, Ruiz-Soto R, Kaye JA, Awan F. Clinical efficacy and safety in relapsed/refractory mantle cell lymphoma: a systematic literature review. Clin Lymphoma Myeloma Leuk. 2015 Jan; 15(1):1-12.e7. PMID: 25052050; DOI: 10.1016/j.clml.2014.03.006;

Bui CL, Kaye JA, Castellsague J, Calingaert B, McQuay LJ, Riera-Guardia N, Saltus CW, Quinlan SC, Holick CN, Wahl PM, Suzart K, Rothman KJ, Wallander MA, Perez-Gutthann S. Validation of acute liver injury cases in a population-based cohort study of oral antimicrobial users. Curr Drug Saf. 2014 Mar; 9(1):23-8.View Related Profiles.

Kaye, James
Rothman, Kenneth

PMID: 24111729

Colosia A, Njue A, Trask PC, Olivares R, Khan S, Abbe A, Police R, Wang J, Ruiz-Soto R, Kaye JA, Awan F. Clinical efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma: a systematic literature review. Clin Lymphoma Myeloma Leuk. 2014 Oct; 14(5):343-355.e6. PMID: 24768510; DOI: 10.1016/j.clml.2014.02.012;

Kaye JA, Castellsague J, Bui CL, Calingaert B, McQuay LJ, Riera-Guardia N, Saltus CW, Quinlan S, Holick CN, Wahl PM, Suzart K, Rothman KJ, Wallander MA, Perez-Gutthann S. Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study. Pharmacotherapy. 2014; 34(4):336-49.View Related Profiles.

Kaye, James
Rothman, Kenneth

PMID: 24865821; PMCID: PMC4260122; DOI: 10.1002/phar.1367;

Mitra D, Kaye JA, Piecoro LT, Brown J, Reith K, Mughal TI, Sarlis NJ. Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record review. Cancer Med. 2013 Dec; 2(6):889-98. PMID: 24403262; PMCID: PMC3892393; DOI: 10.1002/cam4.136;

Meyers J, Yu Y, Kaye JA, Davis KL. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Appl Health Econ Health Policy. 2013 Jun; 11(3):275-86. PMID: 23677706; DOI: 10.1007/s40258-013-0032-2;

Sherrill B, Kaye JA, Sandin R, Cappelleri JC, Chen C. Review of meta-analyses evaluating surrogate endpoints for overall survival in oncology. Onco Targets Ther. 2012; 5:287-96. PMID: 23109809; PMCID: PMC3481854; DOI: 10.2147/OTT.S36683;

Trask PC, Mitra D, Iyer S, Candrilli SD, Kaye JA. Patterns and prognostic indicators of response to CML treatment in a multi-country medical record review study. Int J Hematol. 2012 May; 95(5):535-44. PMID: 22461032; DOI: 10.1007/s12185-012-1043-8;

Mitra D, Trask PC, Iyer S, Candrilli SD, Kaye JA. Patient characteristics and treatment patterns in chronic myeloid leukemia: evidence from a multi-country retrospective medical record chart review study. Int J Hematol. 2012 Mar; 95(3):263-73. PMID: 22351162; DOI: 10.1007/s12185-012-1010-4;

Chirila C, Odom D, Devercelli G, Khan S, Sherif BN, Kaye JA, Molnár I, Sherrill B. Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer. Int J Colorectal Dis. 2012 May; 27(5):623-34. PMID: 22076612; DOI: 10.1007/s00384-011-1349-7;

Odom D, Barber B, Bennett L, Peeters M, Zhao Z, Kaye J, Wolf M, Wiezorek J. Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab. Int J Colorectal Dis. 2011 Feb; 26(2):173-81. PMID: 21190026; PMCID: PMC3024508; DOI: 10.1007/s00384-010-1112-5;

Colosia AD, Peltz G, Pohl G, Liu E, Copley-Merriman K, Khan S, Kaye JA. A review and characterization of the various perceptions of quality cancer care. Cancer. 2011 Mar 01; 117(5):884-96. PMID: 20939015; PMCID: PMC3073118; DOI: 10.1002/cncr.25644;

Yong M, Schoonen WM, Li L, Kanas G, Coalson J, Mowat F, Fryzek J, Kaye JA. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol. 2010 Jun; 149(6):855-64.View Related Profiles.

Kaye, James
Li, Lin

PMID: 20377590; DOI: 10.1111/j.1365-2141.2010.08176.x;

Jick SS, Hagberg KW, Hernandez RK, Kaye JA. Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism. Contraception. 2010 Jan; 81(1):16-21.View Related Profiles.

Kaye, James
Jick, Susan

PMID: 20004268; DOI: 10.1016/j.contraception.2009.07.004;

Andrews EB, Kaye JA, Van Bennekom C. The REMS publication paradox. Oncology (Williston Park). 2009 Jul; 23(8):715-7. PMID: 19711587

Jick SS, Hagberg KW, Kaye JA, Jick H. The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database. Contraception. 2009 Aug; 80(2):142-51.View Related Profiles.

Jick, Hershel
Kaye, James
Jick, Susan

PMID: 19631789; DOI: 10.1016/j.contraception.2009.02.013;

Schoonen WM, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, Fryzek J, Kaye JA. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol. 2009 Apr; 145(2):235-44.View Related Profiles.

Kaye, James
Li, Lin

PMID: 19245432; DOI: 10.1111/j.1365-2141.2009.07615.x;

Jick SS, Hagberg KW, Kaye JA, Jick H. Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer. Obstet Gynecol. 2009 Jan; 113(1):74-80.View Related Profiles.

Jick, Hershel
Kaye, James
Jick, Susan

PMID: 19104362; DOI: 10.1097/AOG.0b013e31818fdde4;

Kaye JA, Jick H. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors. Pharmacotherapy. 2008 Aug; 28(8):951-9.View Related Profiles.